Atlas Trials

Tenaya Therapeutics

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Tenaya Therapeutics

RecordFirmDate
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC (NCT06228924)Tenaya Therapeutics2024-03-26
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM (NCT05836259)Tenaya Therapeutics2023-08-10
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (NCT06311708)Tenaya Therapeutics2023-01-31
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy (NCT05112237)Tenaya Therapeutics2021-11-01

Track Tenaya Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.